Bacterial meningitis is a disease with a high fatality rate and the chance of developing severe complications are more, which include hearing loss, seizures, limb weakness, and difficulties with vision, speech, language, memory, and communication. During bacterial meningitis, cerebrospinal fluid(CSF) glucose level decreases owing to increased glycolysis, impaired glucose transport, or consumption by microorganisms. The prompt estimation of CSF glucose helps decide whether to use antibiotics in patients suspected of bacterial meningitis. This study is done to determine whether a point of care device(glucometer) can be used as an alternative to estimate CSF glucose level by finding the correlation between CSF glucose values obtained by glucometer and autoanalyzer. CSF samples that are clear and not contaminated with blood received by the Biochemistry laboratory, Osmania General Hospital, during the study period were analyzed in this cross-sectional study. Glucose level is estimated in CSF samples using an amperometric glucometer. Also, the glucose level is estimated in the CSF samples by autoanalyzer via hexokinase method, which is considered as the reference method. The CSF glucose values obtained by the two methods are compared by linear regression analysis. The mean value of CSF glucose measured by autoanalyzer is 59.26 ±29.02 mg/dl, and the mean value measured by glucometer is 65.01±30.56mg/dl. The percentage bias for CSF glucose measurement by glucometer is 9.60 percent. The correlation coefficient measured by linear regression analysis is 0.9846. The standard error is 5.35mg/dl. The glucometer could not detect CSF glucose values below 20 mg/dl (measured by autoanalyzer). The glucometer indicated a low value for 28 of 32 samples with glucose values below 20mg/dl (displayed as 'low'). For the remaining four samples, glucometer showed a higher mean value with a percentage bias of 53.2 percent. Thus, a glucometer can help to detect low CSF glucose values in bacterial meningitis. The comparison of CSF glucose estimation by glucometer with autoanalyzer (reference method) gives a correlation coefficient of 0.9846. Also, the glucometer detected values below 20 mg/dl as low values (displayed as 'low'). Therefore, a glucometer can be used for point-of-care estimation of CSF glucose so that initiation of treatment with antibiotics is not delayed.

1. World Health Organisation website: Meningitis Available on https://www.who.int/news-room/fact-sheets/detail/meningitis
2. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Edited by CA Burtis, ER Ashwood, DE Bruns, St. Louis, MO, Elsevier Saunders, 2012
3. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010; 23:467-92.
4. Akram DS, Shaikh AM. Determination of cerebrospinal fluid sugar by glucometer. The JPMA 2002; 52:422-3
5. Rousseau G, Asmolov R, Grammatico-Guillon L et al. Rapid detection of bacterial meningitis using a point-of-care glucometer. Eur J Emerg Med 2017.
6. Tunkel AR, Hartman BJ, Kaplan SL et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267-84
7. Guidelines for the Early Clinical and Public Health Management of Bacterial Meningitis (including Meningococcal Disease): Report of the Scientific Advisory Committee of HPSC. Published in January 2012, Revised in November 2016.
8. Silver TS, Todd JK. Hypoglycorrhachia in pediatric patients. Pediatrics. 1976; 58:67–71.
9. Klepper J, Leiendecker B. GLUT1 deficiency syndrome-2007 update. Dev Med Child Neurol. 2007; 49:707–716.
10. Atlanta (GA): Centers for Disease Control and Prevention; 2016. Epidemiology of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae, 2016
11. Huang H., Zhao G., Dou W. Portable and quantitative point-of-care monitoring of Escherichia coli O157: H7 using a personal glucose meter based on immunochromatographic assay. Biosens. Bioelectron. 2018; 107:266–271.
12. St-Louis P. Status of point-of-care testing: Promise, realities, and possibilities. Clin. Biochem. 2000; 33:427–440.
13. Steven Thomas, Anne Catherine Halstead,M. Joanne Douglas,Giselle Villar Cerebrospinal Fluid Glucose Measurement at Point-of-Care;June 2012;Point of Care The Journal of Near-Patient Testing & Technology 11(2):73-76
14. Saseedharan Sanjith, Mahajan Kaustubh S. Correlation between CSF Glucose Estimation using Glucometers against the Conventional Laboratory Technique in Determining Bacterial Meningitis: An Indian Study.JAPI ,2020 vol 68.
15. Kitsommart R, Wongsinin T, Swasee U, Paes B. Accuracy of Using a Point-of-Care Glucometer for Cerebrospinal Fluid Glucose Screening in Resource-Limited Countries. Hosp Pediatr. 2019 Sep;9(9):665-672. doi: 10.1542/hpeds.2019-0003. PMID: 31434686.
16. Alkhalifah AS, Alqatari KA, Alkhalifa AA, Akakah BA, Alobaid ZS. Sensitivity and specificity of cerebrospinal fluid glucose measurement by an amperometric glucometer. Saudi Med J. 2020 Jun;41(6):602-606. doi: 10.15537/smj.2020.6.25118. Erratum in: Saudi Med J. 2020 Aug;41(8).